1. Home
  2. YPF vs NBIX Comparison

YPF vs NBIX Comparison

Compare YPF & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo YPF Sociedad Anonima

YPF

YPF Sociedad Anonima

N/A

Current Price

$36.04

Market Cap

18.4B

Sector

Energy

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$170.37

Market Cap

17.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YPF
NBIX
Founded
1977
1992
Country
Argentina
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4B
17.7B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
YPF
NBIX
Price
$36.04
$170.37
Analyst Decision
Buy
Strong Buy
Analyst Count
13
28
Target Price
$60.78
★ $208.11
AVG Volume (30 Days)
1.3M
★ 1.3M
Earning Date
10-29-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.95
EPS
N/A
★ 5.26
Revenue
N/A
★ $161,626,000.00
Revenue This Year
$58.16
$39.52
Revenue Next Year
N/A
$14.81
P/E Ratio
★ N/A
$33.11
Revenue Growth
N/A
★ 977.51
52 Week Low
$32.74
$122.14
52 Week High
$57.87
$186.12

Technical Indicators

Market Signals
Indicator
YPF
NBIX
Relative Strength Index (RSI) 20.22 69.21
Support Level $36.04 $169.01
Resistance Level $39.96 $183.65
Average True Range (ATR) 2.01 5.20
MACD -0.99 2.64
Stochastic Oscillator 3.73 87.43

Price Performance

Historical Comparison
YPF
NBIX

About YPF YPF Sociedad Anonima

YPF SA is an Argentina-based integrated oil and gas company. The company operates through four business segments: Upstream, Midstream and Downstream, LNG and Integrated Gas, and New Energies. The Upstream segment focuses on the exploration and production of crude oil and natural gas. The Midstream and Downstream segment includes refining, transportation, and commercialization of crude oil, refined, and petrochemical products. The LNG and Integrated Gas segment is involved in natural gas transportation, processing, storage, and commercialization. The New Energies segment focuses on energy transition initiatives, including natural gas distribution, power generation, renewable energy, and related technology development. It generates majority of revenue from Midstream and Downstream segment.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: